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INTRODUCTION 
The research involving mesoporous silica is continuing to expand since their 
discovery by the Mobil research scientists about a couple of decades ago [1]. The ease of 
producing porous, monodispersed silica materials with particle size dimension ranging 
in few hundred nanometers have attracted a wide range of applications [2]. As these 
silica nanoparticles can hold a relatively large amount of host cargo compared to their 
volume, there particles act as nanocarriers and often find interesting applications ranging 
from drug delivery to bio-sensing [3]. Mesoporous silica nanomaterials are typically 
synthesized from surfactant molecules acting as a templates or structure driving 
assembly. The pore diameters, orderedness of pores, pore wall thickness etc. can be 
easily controlled by choosing a particular type of surfactant molecule and varying the 
reaction conditions [4]. Such chemical control provides a pathway to generate 
engineered mesoporous silica materials that can have a very high surface area up to 1000 
m
2/g and the pore diameters can also be varied from 2 to 10 nm. As a result, these 
porous materials can act excellent host for a wide range of biomolecules. Further 
chemical functionalization of the pore wall surface of the silica is also possible so that 
using non-covalent interactions e.g. electrostatic, hydrogen bonding and van der Waal 
interaction, molecular cargos can be stored inside the porous channels of these materials. 
For such flexibility of making tailored porous silica, these materials exhibit much higher 
loading of host molecules compared to that possible using liposome or other polymer 
conjugates. 
2 
 
In this project, we intended to develop a silica nanoparticle based drug delivery 
system, which is designed to work for colon cancer model. Colorectal cancer or colon 
cancer is one of the major causes of human mortality in the world [5]. In every year, 
several hundred thousands of patients are diagnosed with colon cancer throughout the 
world. Most of these patients undergo chemotherapy as treatment. However, 
chemotherapy itself has harmful side effects on human body. In this work we have 
proposed a silica nanoparticle based model that is designed to deliver drug molecules 
selectively in the cancer tissues of the colorectal region. We have synthesized silica 
nanoparticles via a surfactant template method. These silica nanoparticles are first 
loaded with an anticancer drug and then capped with guar gum polymer. Guar gum is a 
natural non-ionic polysaccharide obtained from a type of leguminous plant Cyamopsis 
tetragonoloba, which is predominantly grown in India [6]. The structure of the guar gum 
polymer is shown below in Figure 1. 
 
Figure 1. Structure of Guar gum (carbohydrate) 
 Guar gum consists of a linear backbone of 
a randomly linked α-1,6
solubility in aqueous medium and thus the polymer forms a viscous solution in water. 
According to the
β-D-glucosidase, β-D
region [5]. These enzymes are
like guar gum. We hypothesize that when guar gum
(preloaded with drugs)
glycosidase enzymes
molecules from silica nanoparticles would be released 
cells. Since the enzyme is present only in the 
drug would be site specific. We also plan to use this silica nanoparticle based drug 
carriers as oral drug delivery system. Once ing
colons and other tissues of the gastrointestinal system but the drugs will only be 
delivered in the colon
nanoparticle based drug delivery system 
Figure 2. Shematic of guar gum capped silica nanoparticle based drug delivery system
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EXPERIMENTAL 
Part A: synthesis of silica nanoparticles 
Materials: n-cetyltrimethylammonium bromide (CTAB), tetraethylorthosilicate 
(TEOS), sodium hydroxide (NaOH), hydrochloric acid (HCl), methanol and ethanol 
were obtained commercially from Aldrich and used as received. De-ionized (DI) water 
was obtained from Millipore ® standard de-ionizer equipment. 
 Synthesis: A mixture of CTAB (250 mg, 0.69 mmol), NaOH (2M 875 µl) and 
DI water (120.0 mL) were heated at 80o C in an oil bath with constant stirring to get a 
clear solution. To this clear solution, TEOS (1.25 ml, 5.59 mmol) was added with the 
help of a syringe at a flow rate of 1.25 mL/min. A white precipitate was observed after 7 
min 30 seconds from the start of the addition. The reaction mixture was stirred at 80o C 
for 2 h. The product was isolated by a hot filtration, washed with water first and then 
ethanol three times each and dried under vacuum. The yield of the product was 458.6 
mg. The product was then subjected to surfactant wash. In a typical washing method, the 
product (458.6 mg) was refluxed in methanol (60.0 mL) with hydrochloric acid (12 N, 
2.3 mL) at 65o C for 24 h. The resulting surfactant washed solid product was filtered off 
and washed with water and methanol several times before drying it under vacuum. The 
yield of the final washed product was 228.8 mg. 
Control experiment: NaOH (2M 875 µl) and DI water (120.0 mL) were heated at 
80o C in an oil bath with constant stirring to get a clear solution. To this clear solution, 
TEOS (1.25 ml, 5.59 mmol) was added with the help of a syringe at a flow rate of 1.25 
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mL/min. The reaction mixture was stirred at 80o C for 2 h. At the end CTAB was added 
because no precipitate was obtained. The product was isolated by a hot filtration, 
washed with water first and then ethanol three times each and dried under vacuum.  
Part B: synthesis of functionalized silica nanoparticles prepared by co-
condensation method 
Materials: n-cetyltriethylammonium bromide (CTAB), tetraethylorthosilicate (TEOS), 
3-aminopropyltriethoxysilane (3-APTES) and 3-marcaptopropyltriethoxysilane (3-
MPTES), sodium hydroxide (NaOH), hydrochloric acid (HCl), methanol and ethanol 
were obtained commercially from Aldrich and used as received. De-ionized (DI) water 
was obtained from Millipore ® standard de-ionizer equipment. 
a) Synthesis of Primary amine functionalized silica nanoparticles: A mixture of 
CTAB (0.25 g, 0.69 mmol), 2M aq. NaOH (0.875 mL) and DI water (120.0 mL) were 
heated at 80o C in an oil bath with constant and vigorous stirring to get a clear solution. 
To this clear solution, TEOS (1.25 mL, 5.59 mmol) and 3-APTMS (0.25 mL, 1.03 
mmol) were added simultaneously by syringes. The entire addition process was carried 
out for 1.0 min. A white precipitate was observed after 2 min 4 seconds from the start of 
the addition. The reaction mixture was stirred vigorously at 80o C for 2 h. The product 
was isolated by a hot filtration, washed with water first and then ethanol three times each 
and dried under vacuum. The yield of the product was 564.1 mg. The product was then 
subjected to surfactant wash. The product (564.1 mg) was refluxed in methanol (60.0 
mL) with hydrochloric acid (12 N, 2.3 mL) at 65o C for 6 h. The resulting surfactant 
washed solid product was filtered off and washed with water and methanol several times 
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before drying it under vacuum. The yield of the final washed product was 310.2 mg and 
the sample was designated as PNH2MSN. 
b) Synthesis of thiol-functionalized silica nanoparticles: A mixture of CTAB (0.25 
g, 0.69 mmol), 2M aq. NaOH (0.875 mL) and DI water (120.0 mL) were heated at 80o C 
in an oil bath with constant and vigorous stirring to get a clear solution. To this clear 
solution, TEOS (1.25 mL, 5.59 mmol) and 3-MPTES (0.25 mL, 1.03 mmol) were added 
simultaneously by syringes. The entire addition process was carried out for 1.0 min. A 
white precipitate was observed after 2 min 4 seconds from the start of the addition. The 
reaction mixture was stirred vigorously at 80o C for 2 h. The product was isolated by a 
hot filtration, washed with water first and then ethanol three times each and dried under 
vacuum. The yield of the product was 554.1 mg. The product was then subjected to 
surfactant wash. The product (554.1m g) was refluxed in methanol (60.0 mL) with 
hydrochloric acid (12N, 2.3 mL) at 65o C for 6 h. The resulting surfactant washed solid 
product was filtered off and washed with water and methanol several times before 
drying it under vacuum. The yield of the final washed product was 329.5 mg and the 
sample was designated as PSHMSN. 
Part C: study of drug loading and release using silica nanopartilces (MSNP) 
Materials: 5-Fluorouracil (5-FU) drug was commercially obtained from Sigma 
Aldrich. Phosphate buffer saline (PBS) of 1 mM ionic strength at pH 7.4 was prepared 
in distilled water (100 mL) with following composition: 
Sodium chloride (0.8 g), Potassium chloride (0.02 g), disodium hydrogen 
phosphate (0.144 g) and potassium dihydrogen phosphate (0.024 g) 
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Carbonate bicarbonate buffer solution (CBCS) of pH 10.2 was prepared in 
distilled water (100 mL) with following composition: 
Anhydrous Na2CO3 (1.06g, 0.2 M) dissolved in 50 mL distilled water and 
NaHCO3 (0.84 g) dissolved in 50 mL distilled water. From these solutions, Na2CO3 
(27.5 mL), NaHCO3 (22.5 mL) was added and made upto 100 mL with distilled water 
which corresponds to 0.2 M sodium carbonate and bicarbonate buffer.  
The following steps were followed to study the drug release from capped silica 
nanoparticles:  
a) Concentration versus absorbance standard plot of 5-FU. 
b) Loading of 5-FU in silica nanoparticles. 
c) Capping silica with Guar gum  
 
a) Concentration versus absorbance standard plot of 5-FU: 10 mg of 5-FU was 
dissolved in 1 mL of PBS, which will be considered as a stock solution. To 
prepare 100 µg/mL solutions, 100 µL from the stock solution was taken in a 
centrifuge tube and was diluted by PBS using micropipette. 
From this 100 µg/mL solution, concentration from 5 µg/mL to 90 µg/mL 
solutions (each 3 mL) can be prepared by serial dilution. 
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Table for solutions of different concentration: 
 
 
From 10 mg/mL of 5-FU solution, the concentration of 120 µg/mL to 150 µg/mL 
solutions (3 mL each) was prepared. 
Table for solutions of different concentration: 
S.No. 
Concentration of Solution 
(in µg/ml)  
Volume of Solution 
(10 mg/mL) in µL 
UV-Absorbance 
1 120 36 3.545 
2 130 39 3.499 
3 150 45 3.569 
 
S.No. 
Concentration of Solution 
( in µg/mL) 
Volume of solution 
(100 µg/mL) in µL 
UV-Absorbance 
(266nm) 
1 5 150 0.188 
2 10 300 0.375 
3 20 600 0.751 
4 30 900 1.132 
5 40 1200 1.540 
6 50 1500 1.713 
7 60 1800 2.234 
8 70 2100 2.600 
9 80 2400 2.803 
10 90 2700 3.210 
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b) Loading of 5-Fu in silica nanoparticles: PBS (2700 µL), 5-FU solution (300 
µL) and sub-100 MSN (30 mg) were taken in a 10 mL beaker and stirred for 
24 hours. Product was centrifuged at 5000 rpm for 20 minutes. The 
supernatant liquid was isolated in a centrifuge tube to take the UV-
absorbance value and again it was transferred to the residue.  
c) Capping silica with Guar gum: PBS (10 mL), CBCS (10 mL) and 0.1 M HCl 
(10 mL) taken in three 50 mL conical flask respectively. To each conical 
flask 0.1% Guar gum was added and dissolved by stirring. After dissolution, 
3 mL of them was taken in three 10 mL beaker respectively and 15 mg of 
sub-100 MSN was added to each beaker, stirred for 24 hours. Centrifuged (at 
13,000rpm) and the residues obtained were lyophilized. FT-IR data was 
recorded for each sample to analyze for capping of silica nanoparticles (fig. 
16, 17, 18). 
d) Capping silica nanoparticles containing 5-FU with Guar gum:  
3 mL of 80ug/mL concentration of 5-FU was taken in 10 mL beaker. To this was 
added 30 mg of silica nanoparticles, the mixture was stirred for 24 hours at room 
temperature. Subsequently, 0.1% Guar gum was added and dissolved by stirring 
for overnight. The mixture was then centrifuged at 13,000 rpm; supernatant was 
collected to analyze for absorbance (at 266nm).The blank was set against 0.1% 
Guar gum and 80 µg/mL of 5-FU. 
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RESULTS AND DISCUSSION 
Characterization analysis: Scanning electron microscopy (SEM) was conducted 
in FEI-FESEM (Nova nano SEM) operated at 5 kV with gold coating for 2 min. Fourier 
transform infrared analysis (FTIR) was done using a Perkin-Elmer FTIR Spectrometer. 
UV-vis absorbance was measured using Shimadzu, UV-2450 Spectrophotometer.  
Part A: characterization of silica nanoparticles 
The silica nanoparticles were prepared from cetyltrimethylammonium bromide 
(CTAB) based surfactant templates, following a literature reported procedure [7]. After 
the synthesis, the CTAB molecules were removed from the silica structures by washing 
the silica materials in acidic solution. The surfactant washed silica materials were 
analyzed by field emission scanning micrograph (FESEM) after a standard gold coating 
on the silica surface. The SEM image is shown in Figure 2. The higher magnification 
image of the SEM study is also shown in Figure 3. From the SEM results it is evident 
that the silica materials are formed as spherical particles with an average diameter of 
around 100 nm. 
To characterize the elements of the materials, energy dispersive X-ray 
spectroscopy (EDS) analysis was carried out and the results are shown in Figure 5. 
Apart from the Au peaks originating due to gold coating, characteristic X-ray peaks 
from elemental Si and O are the only two other peaks. This result conclusively proves 
that the resulting nanoparticles are made of silica. 
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Figure 3. FESEM image of silica nanoparticles obtained from CTAB templates. 
 
Figure 4. FESEM image of silica nanoparticles at higher magnification. 
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Figure 5. EDS result of silica nanoparticles obtained in FESEM study. 
The purpose for using CTAB molecules as template is to generate pores inside the silica 
nanoparticles. In order to establish that the synthesized silica nanoparticle is indeed 
formed through CTAB template, we conducted a control experiment. In absence of any 
CTAB, we added just the tetraethyl orthosilicate (TEOS) in basic medium but no 
precipitate of silica appeared. In this condition, CTAB was added next and a white 
precipitate was obtained immediately after the addition of surfactant. The resulting 
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material was washed, dried and analyzed by FESEM. The obtained micrograph shows 
that instead of 100 nm sized silica nanoparticles, there is a formation of silica 
agglomerates with no well-defined discrete particle morphology (Figure 6). The result of 
this control experiment indicated that CTAB molecules when added prior to the addition 
of TEOS, generated silica nanoparticles with an average diameter of 100 nm. Since the 
role of the CTAB molecules is to generate pores in silica nanoparticles, we indirectly 
arrive at a conclusion that these silica nanoparticles are expected to contain pores within 
its structures. The pore structures of these silica nanoparticles and the surface area of 
these materials has been characterized by N2 gas adsorption study. 
 
Figure 6. FESEM image of the material generated by control experiment 
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Further characterization of silica nanoparticles were performed using FTIR 
spectroscopy. The FTIR spectrum of surfactant unwashed silica nanoparticles is shown 
in Figure 7. The characteristic CTAB peaks are evident at 2919 cm-1, 2890 cm-1 and at 
1484 cm-1, respectively [8]. 
 
Figure 7. FTIR spectrum of unwashed silica nanoparticles 
 
Figure 8. FTIR spectrum of surfactant washed silica nanoparticles 
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The broad vibration peaks at 3400 cm-1 and 1050 cm-1 confirms the silanol O-H 
stretching and Si-O stretching, respectively. In the FTIR spectrum of surfactant washed 
sample, only the characteristic peaks of CTAB is absent as expected and confirms the 
successful removal of the surfactant molecules. 
 
Figure 9. Plot of N2 gas adsorption data according to BET equation of linear form 
We have carried out N2 gas adsorption analysis of surfactant washed silica 
nanoparticles. The results have been plotted to fit the BET linear equation as shown in 
Figure 9. From the slope and the intercept, we obtained the value of monolayer volume, 
which yielded the specific surface area of 1127 m2/g of silica nanoparticles upon 
calculation. This result indicates that the silica nanoparticles prepared by this surfactant 
template method are indeed mesoporous in nature. Such high surface area can only be 
accounted for if there is the presence of porous channels in mesopore dimension. A 
further study of the porous structure is being carried out at present. 
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Part B: characterization of functionalized silica nanoparticles prepared by co-
condensation method 
We extended our strategy of synthesizing surfactant template guided silica materials to 
prepare organic group functionalized silica nanoparticles. We synthesized a primary 
amine functionalized as well as a thiol functionalized silica nanoparticles by a process 
known as co-condensation method. To prepare primary amine functionalized silica, 3-
aminoproyltriethoxysilane (3-APTES) was added along with TEOS during the synthesis.  
 
Figure 10. FESEM image of amine functionalized silica nanoparticles 
The aminopropyl group is expected to be incorporated in the pore walls of silica 
nanoparticles. Upon removal of the surfactant template, morphology of such amine 
functionalized silica nanoparticles were found to be spherical with an average diameter 
of 100 nm as shown in the FESEM image (Figure 10). For synthesis of thiol 
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functionalized silica nanoparticles, 3-mercatpropyltriethoxysilane was added along with 
TEOS during the condensation step, propyl-mercaptan group is expected to be 
incorporated in the structure of silica nanoparticles. The obtained silica nanoparticles 
were found to have an interesting rod like morphology after removal of surfactants 
(Figure 11). The nanoparticles have average length of 200 nm and average width of 90 
nm. Both amine and thiol functionalized silica nanoparticles were further characterized 
by FTIR spectroscopy (Figure 12-13). 
 
Figure 11. FESEM image of thiol functionalized silica nanoparticles 
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Figure 12. FTIR spectrum of primary amine functionalized silica nanoparticles 
 
Figure 13. FTIR spectrum of thiol functionalized silica nanoparticles 
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Part C: study of drug loading using silica nanopartilces and guar gum capping 
We selected 5-flurouracil (5-FU) drug molecules for loading inside silica nanoparticles. 
We chose the anticancer drug 5-FU because it is water soluble and small enough in size 
to diffuse inside the porous channels of silica nanoparticles. The loading and subsequent 
release of the drug molecules can be tracked by uv-visible spectroscopy as 5-FU shows a 
prominent absorption maxima (λmax) at around 266 nm. 
In the first step, absorption values of aqueous solutions of 5-FU at 266 nm were 
recorded against different concentrations and the results were plotted in the form of a 
standard graph (Figure 14). In order to demonstrate that the silica nanoparticles do not 
show significant loading of drug molecules in absence of any capping agents, we 
conducted a control experiment. We incubated surfactant washed silica nanoparticles 
(unfunctionalized) in concentrated 5-FU solution in pH = 7.4 and found almost no 
change of concentration of the drug solution before and after the drug loading 
experiment (Table 1). This result indicates that without any capping agent, the open 
ended channels of silica nanoparticles are not able to retain any appreciable 
concentration of drug molecules.  
Next, we attempted to coat the silica nanoparticles with guar gum polymer in 
absence of any drug solution to establish the feasibility of guar cum capping. In order to 
find out the most suitable pH of the solution in which guar gum would make efficient 
bonding with silica nanoparticles, we conducted the capping experiment in pH = 1.2, pH 
= 7.4 and pH = 9.6, respectively. 
 Figure 14. Standard plot of absorbance 
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TABLE 1. 
DRUG LOADING EXPERIMENT
Silica nanoparticles loading of 5
(Absorbance data recorded at 266nm)
Concentration of drug solution
before loading
                100 µg/
 
Silica nanoparticles loading of 5
(Absorbance data recorded at 266nm)
Concentration of drug 
before loading
                80  µg/mL
 
20 
vs. concentration in uv-visible
0
0.5
1
1.5
2
2.5
3
3.5
4
0 10 20 30 40 50 60 70 80 90
A
b
so
rb
a
n
ce
 (
a
t 
2
6
6
 n
m
)
Concentration (µg/mL)
 
-FU of (Uncapped): 
 
 
 
Concentration of drug solution 
after  loading
 mL                       99.81  µg/
-FU of conc. 80 µg/mL(Capped with 0.1% Guar gum
 
solution 
 
Concentration of drug solution
after  loading
                56.48  µg/mL
 
 study for 5-FU 
100 110
 
 
 mL 
): 
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The dried samples of guar gum capped silica were analyzed by FTIR spectroscopy to 
find the association between the carbohydrate polymer and silica nanoparticles. FTIR 
spectra of guar gum capped silica nanoparticles carried out in pH 1.2, 7.4 and 9.6 are 
represented in Figure 16, 17 and 18, respectively; while that of pure guar gum polymer 
is shown in Figure 15. Analysis of these FTIR spectra confirms the presence of guar 
gum layer on silica nanoparticles in each one of these silica samples. 
Finally, we used 5-FU solution in PBS buffer (pH = 7.4) to load the drug 
molecules in silica nanoparticles followed by the in situ addition of 0.1% (by volume) 
guar gum for capping process. At the end of the capping procedure, we found an 
appreciable difference of absorbance values of 5-FU solution before and after the drug 
loading experiment. Upon calculation, the loading was found out to be 2.3×10-8 moles of 
5FU drug per mg of silica nanoparticles. This result supports our hypothesis of trapping 
of anticancer drugs inside the porous channels of silica nanoparticles. 
 
Figure 15. FTIR characterization of Guar gum polymer 
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Figure 16. FTIR characterization of guar gum coated silica nanoparticles from guar gum 
solution of pH = 1.2 
 
Figure 17. FTIR characterization of guar gum coated silica nanoparticles from guar gum 
solution of pH = 7.4 
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Figure 18. FTIR characterization of guar gum coated silica nanoparticles from guar gum 
solution of pH = 9.6 
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CONCLUSION 
In this project we aimed to develop a silica nanoparticle based drug delivery 
system, which is designed to be applicable in colon cancer therapy. We have synthesized 
template guided silica nanoparticles of average 100 nm sizes. The involvement of 
surfactant template in the synthesis method indirectly indicates the presence of porous 
channels inside the particles, which is supported by the measured surface area of 1127 
m
2/g by BET analysis. We have utilized a carbohydrate based polymer called guar gum 
as capping agents to trap anticancer drug molecules inside the silica nanoparticles. Also, 
we have successfully demonstrated an appreciable loading of the cancer drug inside the 
capped nanoparticles. In a separate control experiment we have also established that in 
absence of guar gum coating, it is not possible to retain any drug molecules inside the 
silica nanoparticles. 
In future, we plan to demonstrate the in vitro release of the anticancer drug from 
the guar gum capped silica nanoparticles by adding β-D-glucosidase enzyme as release 
trigger. Successful demonstration of this experiment will confirm the proof-of-principle 
application of guar gum capped silica nanoparticles as drug delivery agents for colon 
cancer therapy. Our long term plan is to apply this drug delivery system in small animals 
for in vivo demonstration of our strategy. We believe that our silica nanoparticle based 
delivery system has great potential to be applied as oral drugs for colon cancer therapy. 
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